Search Within

Neha Sanat Korde

Formats
  1. Meeting Abstract (158)
  2. Journal Article (66)
  3. Research Letter (8)
  4. Correspondence (3)
  5. Review (3)
  6. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (239)
  2. Department of Medicine (239)
  3. Hematologic Malignancies, Division of (239)
  4. Myeloma (239)
  5. Survivorship Research (239)
  6. Hematologic Malignancies Research (217)

More Groups

People
  1. Sham Mailankody (191)
  2. Alexander Lesokhin (174)
  3. Hani Hassoun (166)
  4. Malin Hultcrantz (155)
  5. Sergio Giralt (148)
  6. Heather Landau (146)

More People

Years
  1. 2025 (7)
  2. 2024 (44)
  3. 2023 (40)
  4. 2022 (34)
  5. 2021 (15)
  6. 2020 (14)

More Years

Publications
  1. Blood (91)
  2. Clinical Lymphoma, Myeloma and Leukemia (47)
  3. Journal of Clinical Oncology (17)
  4. Leukemia and Lymphoma (11)
  5. Blood Advances (8)
  6. Blood Cancer Journal (8)

More Publications

Publishers
  1. American Society of Hematology (99)
  2. Elsevier Inc. (61)
  3. American Society of Clinical Oncology (17)
  4. Nature Publishing Group (15)
  5. Taylor & Francis Group (11)
  6. Ferrata Storti Foundation (7)

More Publishers

Results (239)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Plasma protease-mediated metabolism of carfilzomib and its implications on clinical effects and side effects
    Meeting Abstract

    Tristan, S. M.; Peer, C. J.; Korde, N.; Nehal, L.; Sham, M.; Landgren, O.; Figg, W. D.
    Blood (2014)

    Fulltext@MSK | Save
  • Obesity and risk of monoclonal gammopathy of undetermined significance: A population-based study
    Meeting Abstract

    Thordardottir, M.; Lund, S. H.; Lindqvist, E. K.; Costello, R.; Burton, D.; Korde, N.; Mailankody, S.; Eiriksdottir, G.; Launer, L. J.; Gudnason, V.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Carfilzomib, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma: Final results from the NCI phase 2 pilot study
    Meeting Abstract

    Landgren, O.; Roschewski, M.; Mailankody, S.; Kwok, M.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; Kazandjian, D.; Zingone, A.; Costello, R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD) testing in newly diagnosed multiple myeloma (MM) patients: A prospective head-to-head assessment of cell-based, molecular, and molecular-imaging modalities
    Meeting Abstract

    Korde, N.; Mailankody, S.; Roschewski, M.; Faham, M.; Kotwaliwale, C.; Moorhead, M.; Kwok, M. L.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Series of hairy cell leukemia patients with co-existent plasma cell disorders
    Meeting Abstract

    Korde, N.; Mailankody, S.; Arons, E.; Braylan, R. C.; Raffeld, M.; Maestri, E.; Yuan, C.; Stetler-Stevenson, M.; Landgren, O.; Maric, I.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Biomarker proteasome levels predict response to combination therapy with carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Korde, N.; Dosani, T.; Simakova, O.; Mailankody, S.; Costello, R.; Roschewski, M.; Yuan, C.; Stetler-Stevenson, M.; Figg, W. D.; Landgren, O.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • The road to treating smoldering multiple myeloma
    Conference Paper

    Korde, N.; Mailankody, S.; Landgren, O.
    Elsevier Inc. (2014)

    Fulltext@MSK | Save
  • Smoldering multiple myeloma: Special considerations surrounding treatment on versus off clinical trials
    Journal Article

    Manasanch, E. E.; Korde, N.; Mailankody, S.; Tageja, N.; Bhutani, M.; Roschewski, M.; Landgren, O.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Smoldering multiple myeloma: Pathophysiologic insights, novel diagnostics, clinical risk models, and treatment strategies
    Journal Article

    Kazandjian, D.; Mailankody, S.; Korde, N.; Landgren, O.
    Clinical Advances in Hematology & Oncology (2014)

    Fulltext@MSK | Save